Scandinavian Real Heart

medical devices

About

Scandinavian Real Heart AB is a Swedish medical technology company based in Västerås, founded in 1999. The company specializes in the design and development of advanced artificial heart devices, focusing on innovative solutions for treating advanced stage heart failure and related cardiac conditions. Their flagship product, the Realheart TAH (Total Artificial Heart), is a patented device that mimics the natural heart's pulsatile flow, enhancing blood circulation for patients needing heart replacement. In addition to the Realheart TAH, the company develops other medical devices, including the RealVAD, a pulsating left ventricle assist device, the PulsePump for heart and lung machines, and a sternal prosthesis for post-surgery recovery. Scandinavian Real Heart is publicly traded on Nasdaq First North Growth Market under the ticker symbol HEART. The company operates with a small team and is dedicated to advancing cardiac care through its innovative products aimed at healthcare providers and institutions specializing in cardiac surgery.

Technologies

Outlook Microsoft Office 365 Google Tag Manager Nginx Bootstrap Framework Mobile Friendly YouTube WordPress.org

Keywords

total artificial hearts artificial organs medical device medical equipment manufacturing biotechnology medical collaboration medical advisory board surgical implantation cardiac pump patient mobility heart pump technology medical device development medical equipment and supplies manufacturing heart surgery research and development clinical trials healthcare technology regulatory approval implantable device product development patented technology dialysis machine quiet artificial heart biomedical engineering heart failure treatment heart disease clinical trial planning regulatory pathway animal testing patient equipment

Location

10 Kopparbergsvaegen, Vaesteras, Vaestmanland County, Sweden, 722 13

Related Companies

Companies in the same industry